| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.12B | $4.24B | $8.72B |
| YoY Revenue Growth % | +186.3% | -51.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.47B | -$803.0M | $3.14B |
| Operating Margin % | 20.4% | -19.0% | 36.0% |
| Net Income (GAAP) | $1.82B | -$714.0M | $2.42B |
| EBITDA (Normalized) | $4.66B | $442.6M | $3.46B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.58B | $1.56B | $2.38B |
| Capital Expenditures (CapEx) | $2.74B | $1.56B | $392.4M |
| Free Cash Flow (FCF) | $1.84B | $8.0M | $1.99B |
| FCF Margin % | 15.2% | 0.2% | 22.8% |
| Return on Invested Capital (ROIC %) | 8.5% | -2.8% | 35.8% |
| Cash & Short-Term Equivalents | $616.0M | $317.0M | — |
| Total Debt (Short + Long Term) | $5.01B | $5.29B | $2.69B |
| Total Stockholders' Equity | $18.58B | $17.57B | $5.51B |